Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays

Journal of Medical Virology

Volumn 73, Issue 4, 2004, Pages 508-515

  Jeantet, Damien ^a   Chemin, Isabelle ^a   Mandrand, Bernard ^b   Tran, Albert ^c   Zoulim, Fabien ^a,d   Merle, Philippe ^a,d   Trepo, Christian ^a,d   Kay, Alan ^a  

^a INSERM   (France)

^b UNIVERSITÉ DE LYON   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^d Service d'Hepato Gastroenterologie   (France)

Author keywords

HBV; Mutants; Surface antigen expression; Transcription; Transfection

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; UNCLASSIFIED DRUG; WT ANTIGEN;

ADULT; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLONING; CONTROLLED STUDY; DISEASE MARKER; EXPRESSION VECTOR; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; MALE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; SEQUENCE ANALYSIS; VIRUS DETECTION; VIRUS INFECTION; VIRUS ISOLATION; VIRUS MUTANT; VIRUS MUTATION; VIRUS REPLICATION;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; CELL LINE; CLONING, MOLECULAR; DNA, VIRAL; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATOCYTES; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; REAGENT KITS, DIAGNOSTIC; TRANSCRIPTION, GENETIC; TRANSFECTION;

HEPATITIS B VIRUS; VECTORS;

EID: 3042740361     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20119     Document Type: Article

References (38)

1. Baginski I, Chemin I, Hantz O, Pichoud C, Jullien AM, Chevre JC, Li JS, Vitvitski L, Sninsky JJ, Trepo C. 1992. Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis. Transfusion 32:215-220.
2. Bedossa P, Poynard T. 1996. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24:289-293.
3. Blackberg J, Kidd-Ljunggren K. 2000. Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation. J Hepatol 33:992-997.
4. Blum HE, Liang TJ, Galun E, Wands JR. 1991. Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection. Hepatology 14:56-63.
5. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC. 1990. Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325-329.
6. Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R. 1995. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 345:1406-1407.
7. Chazouilleres O, Mamish D, Kim M, Carey K, Ferrell L, Roberts JP, Ascher NL, Wright TL. 1994. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet 343:142-146.
8. Chemin I, Jeantet D, Kay A, Trepo C. 2001a. Role of silent hepatitis B virus in chronic hepatitis B surface antigen(-) liver disease. Antiviral Res 52:117-123.
9. Chemin I, Zoulim F, Merle P, Arkhis A, Chevallier M, Kay A, Cova L, Chevallier P, Mandrand B, Trepo C. 2001b. High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. J Hepatol 34:447-454.
10. Chen WN, Oon CJ, Toh I. 2000. Altered antigenicities of hepatitis B virus surface antigen carrying mutations outside the common "a" determinant. Am J Gastroenterol 95:1098-1099.
11. El-Serag HB, Mason AC. 1999. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340:745-750.
12. Fong TL, DI Bisceglie AM, Gerber MA, Waggoner JG, Hoofnagle JH. 1993. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Hepatology 18:1313-1318.
13. Galibert F, Mandart E, Fitoussi F, Tiollais P, Charnay P. 1979. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 281:646-650.
14. Grethe S, Monazahian M, Bohme I, Thomssen R. 1998. Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigen-negative subject. J Virol 72:7692-7696.
15. Grob P, Jilg W, Bornhak H, Gerken G, Gerlich W, Gunther S, Hess G, Hudig H, Kitchen A, Margolis H, Michel G, Trepo C, Will H, Zanetti A, Mushahwar I. 2000. Serological pattern "anti-HBc alone": Report on a workshop. J Med Virol 62:450-455.
16. Gunther S, Li BC, Miska S, Kruger DH, Meisel H, Will H. 1995. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 69:5437-5444.
17. Hoofnagle JH, Seefe LB, Bales ZB, Zimmerman HJ. 1978. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 298:1379-1383.
18. Hsu HY, Chang MH, Ni YH, Lin HH, Wang SM, Chen DS. 1997. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. Hepatology 26:786-791.
19. Ireland JH, O'Donnell B, Basuni AA, Kean JD, Wallace LA, Lau GK, Carman WF. 2000. Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology 31:1176-1182.
20. Jeantet D, Chemin I, Mandrand B, Zoulim F, Trepo C, Kay A. 2002. Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient. Hepatology 35:1215-1224.
21. Jongerius JM, Wester M, Cuypers HT, van Oostendorp WR, Lelie PN, van der Poel CL, van Leeuwen EF. 1998. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion 38:56-59.
22. Kessler HH, Preininger S, Stelzl E, Daghofer E, Santner BI, Marth E, Lackner H, Stauber RE. 2000. Identification of different states of hepatitis B virus infection with a quantitative PCR assay. Clin Diagn Lab Immunol 7:298-300.
23. Kremsdorf D, Garreau F, Duclos H, Thiers V, Schellekens H, Petit MA, Brechot C. 1993. Complete nucleotide sequence and viral envelope protein expression of a hepatitis B virus DNA derived from a hepatitis B surface antigen-seronegative patient. J Hepatol 18:244-250.
24. Loriot MA, Marcellin P, Walker F, Boyer N, Degott C, Randrianatoavina I, Benhamou JP, Erlinger S. 1997. Persistence of hepatitis B virus DNAin serum and liver from patients with chronic hepatitis B after loss of HBsAg. J Hepatol 27:251-258.
25. Ogata N, Zanetti AR, Yu M, Miller RH, Purcell RH. 1997. Infectivity and pathogenicity in chimpanzees of a surface gene mutant of hepatitis B virus that emerged in a vaccinated infant. J Infect Dis 175:511-523.
26. Oon CJ, Wei Ning C, Shiuan K, Gek Keow L. 1999. Identification of hepatitis B surface antigen variants with alterations outside the "a" determinant in immunized Singapore infants. J Infect Dis 179:259-263.
27. Persson B, Argos P. 1994. Prediction of transmembrane segments in proteins utilising multiple sequence alignments. J Mol Biol 237:182-192.
28. Pichoud C, Seigneres B, Wang Z, Trepo C, Zoulim F. 1999. Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance. Hepatology 29:230-237.
29. Pillonel J, Saura C, Courouce AM. 1998. Prevalence of HIV, HTLV, and hepatitis B and C viruses in blood donors in France, 1992-1996. Transfus Clin Biol 5:305-312.
30. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. 1996. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 334:1685-1690.
31. Shiota G, Oyama K, Udagawa A, Tanaka K, Nomi T, Kitamura A, Tsutsumi A, Noguchi N, Takano Y, Yashima K, Kishimoto Y, Suou T, Kawasaki H. 2000. Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: Involvement of HBx and p53. J Med Virol 62:151-158.
32. Thiers V, Nakajima E, Kremsdorf D, Mack D, Schellekens H, Driss F, Goudeau A, Wands J, Sninsky J, Tiollais P, et al. 1988. Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet 2:1273-1276.
33. Thiers V, Lunel F, Valla D, Azar N, Fretz C, Frangeul L, Huraux JM, Opolon P, Brechot C. 1993. Post-transfusional anti-HCV-negative non-A non-B hepatitis (II) serological and polymerase chain reaction analysis for hepatitis C and hepatitis B viruses. J Hepatol 18:34-39.
34. Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Melzer JS, Roberts JP, Tomlanovich SJ, Vincenti F, et al. 1995. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation 59:230-234.
35. Weinberger KM, Zoulek G, Bauer T, Bohm S, Jilg W. 1999. A novel deletion mutant of hepatitis B virus surface antigen. J Med Virol 58:105-110.
36. Weinberger KM, Bauer T, Bohm S, Jilg W. 2000. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 81:1165-1174.
37. Zuckerman AJ, Zuckerman JN. 1999. Molecular epidemiology of hepatitis B virus mutants. J Med Virol 58:193-195.
38. Zuckerman JN, Zuckerman AJ. 2003. Mutations of the surface protein of hepatitis B virus. Antiviral Res 60:75-78.